Antiapoptotic Effect of Implanted Embryonic Stem Cell-Derived Early-Differentiated Cells in Aging Rats After Myocardial Infarction

Meixiang Xiang; Jianan Wang; Kaplan, Emel; Oettgen, Peter; Lipsitz, Lewis; Morgan, James P.; Jiang-Yong Min
December 2006
Journals of Gerontology Series A: Biological Sciences & Medical ;Dec2006, Vol. 61 Issue 12, p1219
Academic Journal
This study tested whether implanted embryonic stem cell-derived early-differentiated cells (EDCs) lead to improvement in cardiac function by preventing cardiac apoptosis in aging rats after myocardial infarction. Cardiac apoptosis after transplantation of EDCs was assessed in situ by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling reaction (TUNEL) staining as well as by measurements of protein levels of cleaved caspases 3, Bax, and Bcl-2. Our results indicate that cell transplantation improved cardiac function at 6-months observation. The frequency of apoptotic cells in the peri-infarcted myocardium 3 days after cell transplantation was significantly decreased in the cell transplantation group. EDC therapy decreased the protein levels of cleaved caspase 3 and Bax, and increased the level of Bcl-2 in comparison to myocardial infarction control. Additionally, the number of apoptotic cells decreased significantly in cardiomyocytes precocultured with EDCs. This study demonstrates that functional improvement of EDC transplantation may at least in part be related to a reduction in cardiomyocyte apoptosis.


Related Articles

  • Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Laflamme, Michael A.; Chen, Kent Y.; Naumova, Anna V.; Muskheli, Veronica; Fugate, James A.; Dupras, Sarah K.; Reinecke, Hans; Chunhui Xu; Hassanipour, Mohammad; Police, Shailaja; O'Sullivan, Chris; Collins, Lila; Yinhong Chen; Minami, Elina; Gill, Edward A.; Ueno, Shuichi; Chun Yuan; Gold, Joseph; Murry, Charles E. // Nature Biotechnology;Sep2007, Vol. 25 Issue 9, p1015 

    Cardiomyocytes derived from human embryonic stem (hES) cells potentially offer large numbers of cells to facilitate repair of the infarcted heart. However, this approach has been limited by inefficient differentiation of hES cells into cardiomyocytes, insufficient purity of cardiomyocyte...

  • Stem Cells for Heart Health. Hampton, Tracy // JAMA: Journal of the American Medical Association;10/3/2007, Vol. 298 Issue 13, p1506 

    This article looks at a study out of the University of Washington in Seattle that says cardiac muscle cells taken from human embryonic stem cells may help repair heart damage after myocardial infarction. The researchers transplanted cardiomyocytes into rats who had suffered a heart attack and...

  • Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro. Heng, Boon Chin; Haider, Husnain Kh; Sim, Eugene Kwang-Wei; Cao, Tong; Ng, Soon Chye // Cardiovascular Research;Apr2004, Vol. 62 Issue 1, p34 

    Most studies on stem cell transplantation therapy on myocardially infarcted animal models and phase-I human clinical trials have focused on the use of undifferentiated stem cells. There is a strong possibility that some degree of cardiomyogenic differentiation of stem cells in vitro prior to...

  • Differentiation of human embryonic germ cells and transplantation in rats with acute myocardial infarction. SHUICHANG YU; YANBO ZHU; FANG LI; YUJUAN ZHANG; CHUNLIN XIA // Experimental & Therapeutic Medicine;2014, Vol. 7 Issue 3, p615 

    Human embryonic germ cells (hEGCs) are stem cells cultured from primordial germ cells, which reside in human embryonic genital ridges in vivo. In this study, hEGCs were induced to differentiate into cardiomyocy tes by treatment with ascorbic acid in vitro and the effects of hEGC transplantation...

  • Implantation of Mouse Embryonic Stem Cell-Derived Cardiac Progenitor Cells Preserves Function of Infarcted Murine Hearts. Christoforou, Nicolas; Oskouei, Behzad N.; Esteso, Paul; Hill, Christine M.; Zimmet, Jeffrey M.; Bian, Weining; Bursac, Nenad; Leong, Kam W.; Hare, Joshua M.; Gearhart, John D. // PLoS ONE;2010, Vol. 5 Issue 7, p1 

    Stem cell transplantation holds great promise for the treatment of myocardial infarction injury. We recently described the embryonic stemcell-derived cardiac progenitor cells (CPCs) capable of differentiating into cardiomyocytes, vascular endothelium, and smooth muscle. In this study, we...

  • A Chemical Genetics Approach for Specific Differentiation of Stem Cells to Somatic Cells: A New Promising Therapeutical Approach. Sachinidis, Agapios; Sotiriadou, Isaia; Seelig, Bianca; Berkessel, Albrecht; Hescheler, Jurgen // Combinatorial Chemistry & High Throughput Screening;Jan2008, Vol. 11 Issue 1, p70 

    Cell replacement therapy of severe degenerative diseases such as diabetes, myocardial infarction and Parkinson's disease through transplantation of somatic cells generated from embryonic stem (ES) cells is currently receiving considerable attention for the therapeutic applications. ES cells...

  • Can Mesenchymal Stem Cells Induce Tolerance to Cotransplanted Human Embryonic Stem Cells? Puymirat, Etienne; Geha, Raghed; Tomescot, André; Bellamy, Valérie; Larghero, Jérôme; Trinquart, Ludovic; Bruneval, Patrick; Desnos, Michel; Hagège, Albert; Pucéat, Michel; Menasché, Philippe // Molecular Therapy;Jan2009, Vol. 17 Issue 1, p176 

    Mesenchymal stem cells (MSCs) are reported to be immune privileged. We assessed whether their transplantation (Tx) could create a suppressive microenvironment mitigating rejection of coinjected human embryonic stem cells (hESCs). Three weeks after ligation-induced myocardial infarction, 40...

  • Transplantation of parthenogenetic embryonic stem cells ameliorates cardiac dysfunction and remodelling after myocardial infarction. Liu, Yi; Ye, Xiaoying; Mao, Lina; Cheng, Zhaokang; Yao, Xinpeng; Jia, Xiaohua; Mao, Duo; Ou, Lailiang; Li, Zongjin; Che, Yongzhe; Liu, Na; Steinhoff, Gustav; Liu, Lin; Kong, Deling // Cardiovascular Research;Feb2013, Vol. 97 Issue 2, p208 

    Aims Parthenogenetic embryonic stem cells (pESCs) derived from artificially activated oocytes without fertilization presumably raise minimal ethical concerns and may serve as attractive candidates for regenerative medicine. Here we investigated whether pESCs could repair myocardial infarction...

  • Regulation of PTEN/Akt Pathway Enhances Cardiomyogenesis and Attenuates Adverse Left Ventricular Remodeling following Thymosin β4 Overexpressing Embryonic Stem Cell Transplantation in the Infarcted Heart. Yan, Binbin; Singla, Reetu D.; Abdelli, Latifa S.; Singal, Pawan K.; Singla, Dinender K. // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Thymosin β4 (Tβ4), a small G-actin sequestering peptide, mediates cell proliferation, migration, and angiogenesis. Whether embryonic stem (ES) cells, overexpressing Tβ4, readily differentiate into cardiac myocytes in vitro and in vivo and enhance cardioprotection following...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics